# EDGAR Filing Document

**Accession Number:** 0001677940
**File Stem:** 0001140361-23-008578
**Filing Date:** 2023-2
**Character Count:** 2769
**Document Hash:** 56e86104c6ec488c63a04677442254e8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001140361-23-008578.hdr.sgml**: 20230224

**ACCESSION NUMBER**: 0001140361-23-008578

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230224

**FILED AS OF DATE**: 20230224

**DATE AS OF CHANGE**: 20230224

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BeyondSpring Inc.
- **CENTRAL INDEX KEY:** 0001677940
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38024
- **FILM NUMBER:** 23667910

**BUSINESS ADDRESS:**
- **STREET 1:** 28 LIBERTY STREET
- **STREET 2:** 39TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10005
- **BUSINESS PHONE:** 646-528-4184

**MAIL ADDRESS:**
- **STREET 1:** 28 LIBERTY STREET
- **STREET 2:** 39TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10005

------

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### WASHINGTON, D.C. 20549

### FORM 6-K

#### REPORT OF FOREIGN PRIVATE ISSUER

#### PURSUANT TO RULE 13a-16 OR 15d-16

#### UNDER THE SECURITIES EXCHANGE ACT OF 1934

#### For the month of February 2023

#### Commission File Number: 001-38024

## BeyondSpring Inc.

#### 28 Liberty Street, 39th Floor

#### New York, New York 10005

#### (Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

------

Ramon Mohanlal M.D., Ph.D. has left BeyondSpring Inc. (the "Company") and stopped serving as the Chief Medical Officer and Executive Vice President of Research and Development of the Company and on the Company's Board of Directors (the "Board"), effective February 16, 2023. Dr. Mohanlal's departure is not the result of any disagreement with the Company or the Board on any matter relating to the Company's operations, policies or practices.

This Report on Form 6-K is incorporated by reference into the Registration Statements on Form F-3, File No. 333-257639 and File No. 333-249816, and the Registration Statements on Form S-8, File No. 333-216639 and File No. 333-240082, of the Company.

------

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | BeyondSpring Inc. | BeyondSpring Inc. |
|  | By:  | /s/ Lan Huang |
|  | Name: Lan Huang | Name: Lan Huang |
|  | Title: Chairperson and Chief Executive Officer | Title: Chairperson and Chief Executive Officer |
| Date: February 24, 2023 |  |  |

---

------